W. Capell

发表

Time course of C-reactive protein reduction with simvastatin therapy in patients with type 2 diabetes mellitus.

R. Eckel, P. Wolfe, T. Hernandez, 2006, The American journal of cardiology.

Low-dose rivaroxaban plus aspirin in older patients with peripheral artery disease undergoing acute limb revascularization: insights from the VOYAGER PAD trial.

Manesh R Patel, Sonia S Anand, S. Debus, 2021, European heart journal.

Plant sterols added to combination statin and colesevelam hydrochloride therapy failed to lower low-density lipoprotein cholesterol concentrations.

R. Eckel, J. Saseen, S. Linnebur, 2007, Journal of clinical lipidology.

Prevention of arterial and venous thrombotic events in symptomatic peripheral arterial disease patients after lower extremity revascularization in the VOYAGER PAD trial: Dual anticoagulant/antiplatelet regimen vs antiplatelet therapy alone

R. Diaz, Manesh R Patel, Sonia S Anand, 2022, Journal of thrombosis and haemostasis : JTH.

Rivaroxaban and Aspirin in Peripheral Artery Disease Lower Extremity Revascularization

Manesh R. Patel, H. Sillesen, Manesh R Patel, 2020, Circulation.

Compositional differences of LDL particles in normal subjects with LDL subclass phenotype A and LDL subclass phenotype B.

J. Hokanson, M. Austin, J. Brunzell, 1996, Arteriosclerosis, thrombosis, and vascular biology.

Lack of suppression of circulating free fatty acids and hypercholesterolemia during weight loss on a high-fat, low-carbohydrate diet.

R. Eckel, James O. Hill, H. Wyatt, 2010, The American journal of clinical nutrition.

Therapeutic targets in severe hypertriglyceridemia

R. Eckel, W. Capell, Karuna P. Spiegelman, 2004 .

Rivaroxaban in Peripheral Artery Disease after Revascularization.

Manesh R. Patel, Marc P. Bonaca, Sonia S Anand, 2020, The New England journal of medicine.

A randomized trial of heart failure disease management in skilled nursing facilities (SNF Connect): Lessons learned

H. Wald, D. Fairclough, E. Leister, 2017, Clinical trials.

Treatment of hypertriglyceridemia

R. Eckel, W. Capell, 2006, National Institutes of Health consensus development conference summary.

Sex‐Based Differences in Outcomes Following Peripheral Artery Revascularization: Insights From VOYAGER PAD

Manesh R. Patel, Sonia S Anand, I. Baumgartner, 2022, Journal of the American Heart Association.

Reduction in Acute Limb Ischemia With Rivaroxaban Versus Placebo in Peripheral Artery Disease After Lower Extremity Revascularization: Insights From VOYAGER PAD

Manesh R. Patel, R. Diaz, J. Beckman, 2021, Circulation.

Rationale and design of a study to assess the safety and efficacy of rNAPc2 in COVID-19: the Phase 2b ASPEN-COVID-19 trial

D. Morrow, J. Nicolau, W. Ruf, 2022, American Heart Journal.

1.P.42 Small, dense LDL is associated with low lipoprotein lipase and high hepatic lipase activities, and alterations in IDL and VLDL composition

J. Hokanson, J. Brunzell, A. Zambon, 1997 .

Rivaroxaban and Risk of Venous Thromboembolism in Patients With Symptomatic Peripheral Artery Disease After Lower Extremity Revascularization

Manesh R. Patel, J. Beckman, K. Roztočil, 2022, JAMA network open.

Total Ischemic Event Reduction with Rivaroxaban after Peripheral Arterial Revascularization in the VOYAGER PAD Trial.

Sonia S Anand, M. Brodmann, W. Hiatt, 2021, Journal of the American College of Cardiology.

Severe hypertriglyceridemia with a history of treatment failure

R. Eckel, W. Capell, 2005, Nature Clinical Practice Endocrinology &Metabolism.

Safety and Effectiveness of Paclitaxel Drug-Coated Devices in Peripheral Artery Revascularization: Insights From VOYAGER PAD.

J. Beckman, L. Mauri, Sonia S Anand, 2021, Journal of the American College of Cardiology.

Obesity development in caspase-1-deficient mice

R. Eckel, S. Faubel, J. Yoon, 2014, International Journal of Obesity.

Rivaroxaban in Patients with Symptomatic Peripheral Artery Disease after Lower Extremity Bypass Surgery with Venous and Prosthetic Conduits.

H. Sillesen, L. Norgren, Sonia S Anand, 2022, Journal of vascular surgery.

Should Participants in Clinical Trials Be Able to Withdraw from Passive Follow-Up?

M. Wynia, Elisa A. Hurley, M. Bonaca, 2021, Ethics & human research.

Effect of Rivaroxaban and Aspirin in Patients With Peripheral Artery Disease Undergoing Surgical Revascularization: Insights From the VOYAGER PAD Trial

H. Sillesen, Sonia S Anand, J. Mills, 2021, Circulation.

Rationale and design for the study of rivaroxaban to reduce thrombotic events, hospitalization and death in outpatients with COVID-19: The PREVENT-HD study

Marc P. Bonaca, J. Hsia, S. Bull, 2021, American Heart Journal.

Rationale and design for the Vascular Outcomes study of ASA along with rivaroxaban in endovascular or surgical limb revascularization for peripheral artery disease (VOYAGER PAD)

Marc P. Bonaca, Sonia S Anand, W. Hiatt, 2018, American heart journal.

Increased expression of the SNARE accessory protein Munc18c in lipid-mediated insulin resistance Published, JLR Papers in Press, April 16, 2003. DOI 10.1194/jlr.M300003-JLR200

Isabel R Schlaepfer, R. Eckel, D. James, 2003, Journal of Lipid Research.

Short-Term Triglyceride Lowering With Fenofibrate Improves Vasodilator Function in Subjects With Hypertriglyceridemia

Kathleen M. Weil, R. Eckel, P. Poirier, 2003, Arteriosclerosis, thrombosis, and vascular biology.

A Structured Review of Antithrombotic Therapy in Peripheral Artery Disease With a Focus on Revascularization: A TASC (InterSociety Consensus for the Management of Peripheral Artery Disease) Initiative.

L. Norgren, F. Fowkes, M. Jaff, 2017, Circulation.

Fatty acids increase glucose uptake and metabolism in C2C12 myoblasts stably transfected with human lipoprotein lipase.

R. Eckel, D. Bessesen, P. Watson, 2010, American journal of physiology. Endocrinology and metabolism.

Ethical conduct of palliative care research: enhancing communication between investigators and institutional review boards.

A. Abernethy, J. Kutner, C. Ritchie, 2014, Journal of pain and symptom management.

Exercise Training and Revascularization in the Management of Symptomatic Peripheral Artery Disease

J. Beckman, M. McDermott, W. Hiatt, 2021, JACC. Basic to translational science.

Conducting Clinical Research in Post-acute and Long-term Nursing Home Care Settings: Regulatory Challenges.

Cynthia Drake, C. Levy, A. Gustavson, 2019, Journal of the American Medical Directors Association.

Treatment of hypertriglyceridemia.

R. Eckel, W. Capell, 2006, Current Diabetes Reports.

Novel Tissue Factor Inhibition for Thromboprophylaxis in COVID-19: Primary Results of the ASPEN-COVID-19 Trial

Ian A. Carroll, D. Morrow, M. Effron, 2023, Arteriosclerosis, thrombosis, and vascular biology.

Limb Outcomes With Ticagrelor Plus Aspirin in Patients With Diabetes Mellitus and Atherosclerosis.

A. Himmelmann, J. Prats, M. Kosiborod, 2024, Journal of the American College of Cardiology.

Methods, design, and initial results of an angiographic core lab from VOYAGER-PAD

M. Nehler, S. Berkowitz, R. Bricker, 2024, Vascular medicine.

Low-Dose Rivaroxaban Plus Aspirin in Fragile Patients After Lower Extremity Revascularization.

M. Nehler, S. Berkowitz, E. Muehlhofer, 2024, Journal of the American College of Cardiology.